for the Period Ended 31 December 2025
| Balance sheet | |
| Additional notes | |
| Balance sheet notes | |
| Community Interest Report |
As at
| Notes | 2025 | 2024 | |
|---|---|---|---|
|
|
£ |
£ |
|
| Fixed assets | |||
| Intangible assets: | 3 |
|
|
| Tangible assets: | 4 |
|
|
| Total fixed assets: |
|
|
|
| Current assets | |||
| Debtors: | 5 |
|
|
| Cash at bank and in hand: |
|
|
|
| Total current assets: |
|
|
|
| Creditors: amounts falling due within one year: | 6 |
(
|
(
|
| Net current assets (liabilities): |
( |
( |
|
| Total assets less current liabilities: |
|
|
|
| Total net assets (liabilities): |
|
|
|
| Members' funds | |||
| Profit and loss account: |
|
|
|
| Total members' funds: |
|
|
The notes form part of these financial statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 December 2025
Basis of measurement and preparation
Turnover policy
Tangible fixed assets depreciation policy
Intangible fixed assets amortisation policy
for the Period Ended 31 December 2025
| 2025 | 2024 | |
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 31 December 2025
| Goodwill | Other | Total | |
|---|---|---|---|
| Cost | £ | £ | £ |
| At 1 January 2025 |
|
|
|
| Additions | |||
| Disposals | |||
| Revaluations | |||
| Transfers | |||
| At 31 December 2025 |
|
|
|
| Amortisation | |||
| At 1 January 2025 |
|
|
|
| Charge for year |
|
|
|
| On disposals | |||
| Other adjustments | |||
| At 31 December 2025 |
|
|
|
| Net book value | |||
| At 31 December 2025 |
|
|
|
| At 31 December 2024 |
|
|
|
for the Period Ended 31 December 2025
| Land & buildings | Plant & machinery | Fixtures & fittings | Office equipment | Motor vehicles | Total | |
|---|---|---|---|---|---|---|
| Cost | £ | £ | £ | £ | £ | £ |
| At 1 January 2025 |
|
|
||||
| Additions | ||||||
| Disposals | ||||||
| Revaluations | ||||||
| Transfers | ||||||
| At 31 December 2025 |
|
|
||||
| Depreciation | ||||||
| At 1 January 2025 |
|
|
||||
| Charge for year |
|
|
||||
| On disposals | ||||||
| Other adjustments | ||||||
| At 31 December 2025 |
|
|
||||
| Net book value | ||||||
| At 31 December 2025 |
|
|
||||
| At 31 December 2024 |
|
|
for the Period Ended 31 December 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Trade debtors |
|
|
| Total |
|
for the Period Ended 31 December 2025
| 2025 | 2024 | |
|---|---|---|
| £ | £ | |
| Trade creditors |
|
|
| Accruals and deferred income |
|
|
| Other creditors |
|
|
| Total |
|
|
Nutritank has grown into a recognised voice for nutrition and lifestyle medicine in healthcare. Our work has been acknowledged across medical education, the NHS, and public health, highlighting the importance of nutrition in improving patient outcomes. These achievements reflect our ongoing commitment to supporting healthcare professionals and students with evidence-based education that strengthens prevention and clinical care.
We are in regular contact throughout the year with our stakeholders, who include students, clinicians, and professionals who are keen to bridge the gap between medical education and the growing demand for lifestyle focused health.
£10500 was paid to a director in the year.
No transfer of assets other than for full consideration
This report was approved by the board of directors on
17 June 2026
And signed on behalf of the board by:
Name: I Broadley
Status: Director